CMT Research Foundation logo

CMT Research Foundation

Description

CMT Research Foundation has a single focus: provide treatments and cures for CMT.

Investor Profile

CMT Research Foundation has backed more than 5 startups, with 4 new investments in the last 12 months alone. The firm has led 2 rounds, about 40% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Seed, Series Unknown rounds (top funding stages).
  • Majority of deals are located in Belgium, United States, The Netherlands.
  • Strong thematic focus on Biotechnology, Therapeutics, Biopharma.
  • Led 2 rounds in the past year.

Stage Focus

  • Series A (60%)
  • Seed (20%)
  • Series Unknown (20%)

Country Focus

  • Belgium (40%)
  • United States (40%)
  • The Netherlands (20%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Biopharma
  • Pharmaceutical
  • Alternative Medicine
  • Genetics
  • Health Care
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does CMT Research Foundation frequently co-invest with?

AdBio partners
Europe, Ile-de-France, France, Paris
Co-Investments: 2
Asabys Partners
Europe, Catalonia, Spain, Barcelona
Co-Investments: 2
Gemma Frisius Fund
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 2
VIB
Europe, Oost-Vlaanderen, Belgium, Gent
Co-Investments: 2
Lapam Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
V-Bio Ventures
Europe, Oost-Vlaanderen, Belgium, Gent
Co-Investments: 2
5Y Capital
Asia, Shanghai, China, Xuhui
Co-Investments: 1
CDH Investments
Asia, Kowloon, Hong Kong, Kowloon City
Co-Investments: 1
PMV
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 2
Eli Lilly
North America, Indiana, United States, Indianapolis
Co-Investments: 2

What are some of recent deals done by CMT Research Foundation?

XtRNA Bio

Nieuw-amsterdam, Drenthe, The Netherlands

XtRNA Bio is developing a new class of RNA therapeutics targeting genetic diseases caused by translation defects.

Therapeutics
Series UnknownJun 24, 2025
Asha Therapeutics

Tampa, Florida, United States

Asha Therapeutics is a new advance paradigm of drug discovery for re-engineering cellular machinery.

Health CareMedicalTherapeutics
SeedMay 20, 2025
Augustine Therapeutics

Leuven, Vlaams-Brabant, Belgium

Augustine Therapeutics is discovering and developing innovative medicines for the treatment of neuromuscular and neurodegeneratives diseases

BiopharmaBiotechnologyPharmaceutical
Series AMar 24, 2025
Amount Raised: $84,139,626
ReviR Therapeutics

Brisbane, California, United States

ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.

Alternative MedicineBiotechnologyGeneticsTherapeutics
Series AJul 26, 2024
Amount Raised: $30,000,000
Augustine Therapeutics

Leuven, Vlaams-Brabant, Belgium

Augustine Therapeutics is discovering and developing innovative medicines for the treatment of neuromuscular and neurodegeneratives diseases

BiopharmaBiotechnologyPharmaceutical
Series AJun 26, 2024
Amount Raised: $18,206,938

Find More Investors Like CMT Research Foundation

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

CMT Research Foundation | Pipeseed